Stroma may provide key to better cancer treatment

October 26, 2010

A project focusing on the scar tissue surrounding cancer tumours aims to provide new targets for drugs for treating pancreatic cancer, the fifth highest cause of cancer deaths in the UK.

Funded by the UK charity Pancreatic Cancer Research Fund, the project will research the role of a family of molecules present in this - known as stroma - which are believed to have a role in driving tumour growth.

The project is led by surgeon and researcher Mr Hemant Kocher from Barts and The London School of Medicine and Dentistry.

The research is based on the 'seed and soil' hypothesis, where the cancer is the 'seed' and the stroma the 'soil'. Mr Kocher explains: "We believe the stroma provides the right environment in which the cancer can grow. All cancers have stroma, but in pancreatic cancer, it's markedly more voluminous, which may prevent drug treatments reaching the tumour."

"The pancreatic cancer stroma has not, to date, been targeted as a potential route for treatment," says Mr Kocher. "The survival rate for hasn't improved in around 40 years, and we're hopeful this research will shed greater light on this area."

The team will be conducting in-depth analysis of a family of signalling molecules called Fibroblast Growth Factor (FGF) drawing on knowledge gained through progress in breast cancer research.

"A gene which was found to be implicated in breast cancer has been shown to code a receptor for FGF," says Mr Kocher. "If we can understand how FGF receptor gene regulates cell behaviour, we'll be able to harness this knowledge in the search for better drug treatments."

The research team includes PhD student Stacey Coleman and will draw on the expertise of cell biologist Dr Richard Grose – also at the Institute of Cancer at Barts & The London School of Medicine & Dentistry - who has focused on these mechanisms in the search for more effective treatments.

Explore further: Cell receptor may lead to new 'biomarker' for pancreatic cancer

Related Stories

New molecular therapy candidates for pancreatic cancer

April 19, 2010

A research team from Japan investigated expression of insulin-like growth factor-I receptor (IGF-IR) in pancreatic cancer cell lines. All the cell lines examined expressed IGF-IR under culture conditions without IGF-I in ...

New mechanism of pancreatic cancer discovered

May 31, 2010

(PhysOrg.com) -- A new study from Karolinska Institutet, Sweden, shows how two types of cell change interact in the development of cancer. The results can improve the chances of early discovery of cancer - including pancreatic ...

Protein key to growth of pancreatic cancer

September 28, 2010

The protein could provide a target to develop new treatments for the disease or enable earlier diagnosis, say the researchers from Barts and The London School of Medicine and Dentistry. Pancreatic cancer has the lowest survival ...

New clues on how cancer spreads

October 12, 2010

Researchers have dramatically advanced medicine's understanding of how cancer migrates, showing that cancer cells are accompanied by growth-enabling stromal cells when they travel in the bloodstream to new sites in the body.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.